Abstract:AIM:To study the influence of inducers of drug metabolism enzyme, beta-naphthoflavone (BNF) and dexamethasone (DEX), on the stereoselective metabolism of propafenone in the rat hepatic microsomes.METHODS:Phase I metabolism of propafenone was studied using the microsomes induced by BNF and DEX and the non-induced microsome was used as the control. The enzymatic kinetics parameters of propafenone enantiomers were calculated by regress analysis of Eadie-Hofstee Plots. Propafenone enantiomer concentrations were assayed by a chiral HPLC.RESULTS:The metabolite of propafenone, N-desalkylpropafenone, was found after incubation of propafenone with the rat hepatic microsomes induced by BNF and DEX. In these two groups, the stereoselectivity favoring R(-) isomer was observed in metabolism at low substrate concentrations of racemic propafenone, but lost the stereoselectivity at high substrate concentrations. However, in control group, no stereoselectivity was observed. The enzyme kinetic parameters were: (1) K(m).CONTROL GROUP:R(-) 83+/-6, S(+) 94+/-7; BNF group: R(-) 105+/-6, S(+)128+/-14; DEX group: R(-) 86+/-11, S(+) 118+/-16; (2)V(max).CONTROL GROUP:R(-) 0.75+/-0.16, S(+) 0.72+/-0.07; BNF group: R(-) 1.04+/-0.15, S(+)1.07+/-14; DEX group: R(-) 0.93+/-0.06, S(+) 1.04+/-0.09; (3)Cl(int).CONTROL GROUP:R(-) 8.9+/-1.1, S(+) 7.6+/-0.7; BNF group: R(-) 9.9+/-0.9, S(+)8.3+/-0.7; DEX group: R(-) 10.9+/-0.8, S(+) 8.9+/-0.9. The enantiomeric differences in K(m) and Cl(int) were both significant, but not in V(max), in BNF and DEX group. Whereas enantiomeric differences in three parameters were all insignificant in control group. Furthermore, K(m) and V(max) were both significantly less than those in BNF or DEX group. In the rat liver microsome induced by DEX, nimodipine (NDP) decreased the stereoselectivity in propafenone metabolism at low substrate concentration. The inhibition of NDP on the metabolism of propafenone was stereoselective with R(-)-isomer being impaired more than S(+)-isomer. The inhibition constant (Ki) of S(+)- and R(-)-propafenone, calculated from Dixon plots, was 15.4 and 8.6 mg x L(-1), respectively.CONCLUSION:CYP1A subfamily(induced by BNF) and CYP3A4 (induced by DEX) have pronounced contribution to propafenone N-desalkylation which exhibited stereoselectivity depending on substrate concentration. The molecular base for this phenomenon is the stereoselectivity in affinity of substrate to the enzyme activity centers instead of at the catalyzing sites.

Enzyme kinetics of novel antiepileptic drug 3,4-dichlorophenyl-propenoyl-sec.-butylamine in rat liver microsomes in vitro

Pharmacokinetics and metabolism of 3,4-dichlorophenyl-propenoyl-sec.-butylamine in rats by high performance liquid chromatography-ion trap mass spectrometry.

Interaction Between 3,4‑dichlorophenyl‑propenoyl‑sec.‑butylamine (3,4‑DCPB), an Antiepileptic Drug, and Cytochrome P450 in Rat Liver Microsomes and Recombinant Human Enzymes in Vitro

CHIRAL RP-HPLC ASSAY FOR PROPAFENONE ENANTIOMERS IN RAT LIVER MICROSOMAL INCUBATES AND ITS APPLICATION IN VITRO METABOLISM

Discovery of Novel N,N-3-phenyl-3-benzylaminopropionanilides As Potent Inhibitors of Cholesteryl Ester Transfer Protein in Vivo.

RP-HPLC DETERMINATION OF DIPHENYTRIAZOL IN RAT LIVER MICROSOMAL INCUBATES AND ITS APPLICATION IN IN VITRO METABOLISM

Quantification of Antitumor Caffeic Acid-3,4-Dihydroxybenzylethyl Ester and Its Pharmacokinetic Study in Human Liver Microsomes by LC-MS/MS

In Vitro Metabolism and Inductive or Inhibitive Effect of DL111 on Rat Cytochrome P4501A Enzyme.

In Vitro Metabolism of E2, G2: Novel Bile Acid-Coupling Camptothecin Analogues, in Rat Liver Microsomes

Epigenetic variants of xenobiotic metabolism affect individual differences in antiepileptic drug 3,4-DCPB pharmacokinetic phenotype

Pharmacokinetics of ,4-dichlorophenyl-propenoyl-sec. -butylamine (7903) in rats

Design, Synthesis and Evaluation of 3-(2-aminoheterocycle)-4-benzyloxyphenylbenzamide Derivatives As BACE-1 Inhibitors

Characterization of the Metabolism of Eupalinolide A and B by Carboxylesterase and Cytochrome P450 in Human Liver Microsomes

Particular ability of cytochromes P450 3A to form inhibitory P450-iron-metabolite complexes upon metabolic oxidation of aminodrugs

Discovery of novel cholinesterase inhibitors easily crossing the blood‐brain barrier via structure‐property relationship investigation: Methylenedioxy‐cinnamicamides containing tertiary amine side chain

Chiral Metabolism of Propafenone in Rat Hepatic Microsomes Treated with Two Inducers

Research of in vitro Metabolism of Di-n-butyl-(4-chlorobenzohydroxamato) Tin(IV) Chloride in Rat liver Microsomes

Metabolism of amiodarone (Part III): identification of rabbit cytochrome P450 isoforms involved in the hydroxylation of mono-N-desethylamiodarone

Effect of P-Amino-Diphenyl Ethers on Hepatic Microsomal Cytochrome P450

Metabolism of 4-Aminopiperidine Drugs by Cytochrome P450s: Molecular and Quantum Mechanical Insights into Drug Design

Studies on the Metabolism of 4-Methylpiperazine-1-carbodithioc Acid 3-Cyano-3,3- Diphenylpropyl Ester Hydrochloride in Rat Bile by High-Performance Liquid Chromatography/electrospray Ionization Tandem Mass Spectrometry.